CDIX
OQB Cardiff Lexington Corporation$0.0800 ↑ +0.0200 (+33.33%) Trading Up from the previous close of $0.0600, $0.0200 below the day’s high of $0.1000
- YTD change
- -98.42%
- vs 20-day SMA
- -73.91%
- vs 200-day SMA
- N/A
Price ranges
Price & Performance
-1.82 (-96.81%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 99.3% away from all-time highs of $11.2500
- CDIX is down 98% since the beginning of the year
- CDIX is down 98% over the past 12 months
- CDIX is down 80% over the past 1 month
- 0% of all CDIX investors are betting against CDIX
CDIX reads poor: the 12-month move is -96.3%.
- Previous minute
- +$0.0000
- Last hour
- -$0.0200
- Last 5 days
- -86.67%
- vs 8-day SMA
- -74.32%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Cardiff Lexington Corp. is a holding company, which engages in capitalization and management of private enterprises. It operates through the Healthcare (Nova) and Real Estate (Edge View) segments. The Healthcare (Nova) segment offers diagnostic and surgical services for injuries and disorders of the skeletal system and associated bones, joints, tendons, muscles, ligaments, and nerves. The Real Estate (Edge View) segment consists of Edge View, which owns 30 acres of land. The company was founded in 1986 and is headquartered in Lexington, KY.
Competitor comparison
| Ticker | Company | Price | Change |
|---|---|---|---|
| INGS.CAT | ING GROEP N.V. CDR CIBC REG S | $43.12 | +2.18% |
| BIP.UN.CAT | BROOKFIELD INFRA PARTNERS LP UNITS | $52.01 | +2.16% |
| QBR.B.CAT | QUEBECOR INC CL B | $62.32 | -0.13% |
| TFPM.CAT | TRIPLE FLAG PRECIOUS METAL | $43.60 | +0.67% |
| ONEX.CAT | ONEX CORP SUB VTG | $105.08 | +0.12% |
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.